Scientific publications
A strong scientific valorization of our studies as evidenced by our publications
The ASTRO-LAB project: A European project combining healthcare databases and direct patient follow-up to assess the safety of long-acting ß2 agonists (LABAs) in asthma in routine care
Van Ganse E, Leproust S, Laforest L, Saint-Lary O, Mercier A, Texier N.
6ème forum scientifique de pharmaco-épidémiologie. Paris
Identification dans les bases de l’Assurance Maladie de facteurs associés aux grosses délivrances de bêtas agonistes inhalés à courte durée d’action dans l’asthme
Laforest L, Martin J, Licaj I, Devouassoux G, Chatte E, Van Ganse E.
6ème forum scientifique de pharmaco-épidémiologie. Paris
Impact of Rotavirus gastroenteritis requiring hospitalization or presenting to emergency room among children less than 5 years in France
Parez N, Mory O, Pozzetto B, Garbag-Chenon A, Pillet S, Texier N, Téhard B.
Pathol Biol (Paris). 2012 Oct;60(5):275-81. French.
Use of drug treatments for Alzheimer’s disease in France: a study on a national level based on the National Alzheimer’s Data Bank (Banque Nationale Alzheimer)
Tifratene K, Duff FL, Pradier C, Quetel J, Lafay P, Schück S, Benzenine E, Quantin C, Robert P.
Pharmacoepidemiol Drug Saf. 2012 Sep;21(9):1005-12.
The 2008-2012 French Alzheimer plan: description of the national Alzheimer information system
Le Duff F, Develay AE, Quetel J, Lafay P, Schück S, Pradier C, Robert P; French National Alzheimer dataBank (BNA).
J Alzheimers Dis. 2012;29(4):891-902.
Apathy and Depression in Mild Alzheimer’s Disease: A Cross-Sectional Study Using Diagnostic Criteria. Journal of Alzheimer’s Disease
Benoit M, Berrut G, Doussaint J, Bakchine S, Bonin-Guillaume S, Frémont P, Gallarda T, Krolak-Salmon P, Marquet T, Mékiès C, Sellal F, Schück S, David R, Robert P.
Journal of Alzheimer’s Disease. 1 janv 2012;31(2):325‑34
Apathy and depression in mild Alzheimer’s disease: a cross-sectional study using diagnostic criteria
Benoit M, Berrut G, Doussaint J, Bakchine S, Bonin-Guillaume S, Frémont P, Gallarda T, Krolak-Salmon P, Marquet T, Mékiès C, Sellal F, Schuck S, David R, Robert P.
J Alzheimers Dis. 2012;31(2):325-34.
Bochner F. Drug benefits and risks; International Textbook of Clinical Pharmacology
Schück S, Robert PH, Touchon J.
IOS Press and Uppsala Monitoring Centre. Amsterdam. Chinese Edition
Pooled analysis of individual patient data from European observational studies on zonisamide use in clinical practice: Sub-group comparisons of efficacy
Brodie M, Dupont S, Francia A, Nakken K, Pardo J, Stefan H, Chouette I.
65th annual meeting American Epilepsy Society. Baltimore
Impact of Rotavirus gastroenteritis requiring hospitalization or presenting to emergency room among children less than 5 years in France
Parez N, Mory O, Pozzetto B, Garbag-Chenon A, Pillet S, Texier N, Téhard B.
Pathol Biol (Paris). oct 2012;60(5):275‑81
Control of persistent asthma patients on inhaled corticosteroids in a real-life setting
Devillier P, Godard P, Pribil C, Decuypere L, Gaudin AF, Martin J, Doussaint J, Nachbaur G, Neukirch F, Van Ganse E, Viens G, Roche N.
European Respiratory Society Annual Congress. Barcelone
Mise en place du recueil épidémiologique national et premières tendances. Plan national Alzheimer 2008-2012 – Mesure 34 Mise en place du recueil épidémiologique national et premières tendances
Le Duff F, Duport N, Gonfrier S, Lafay P, Texier N, Schück S, Pradier C, Robert P.
Revue de Gériatrie
Biosimilars: The French policy. International Journal of Risk & Safety in Medicine
Schück S, Texier N.
Int J Risk Safety Med
Seizures in the elderly: development and validation of a diagnostic algorithm.
Dupont S, Verny M, Harston S, Cartz-Piver L, Schück S, Martin J, Puisieux F, Alecu C, Vespignani H, Marchal C, Derambure P.
Epilepsy Res. 2010 May;89(2-3):339-48.
Description de l’activité des CMRR (Centres mémoire, de ressources et de recherches) et CM (Centres mémoire) utilisant le dossier informatisé Calliope
Schück S, Texier N, Dubois B, Dartigues JF, Touchon J, Rouaud O et al.
Cah Annee Gerontol